chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: He reports arm soreness/soreness in arm; This is a spontaneous report received from a contactable Consumer from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 49-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 03Mar2021 16:00 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 05Mar2021, outcome "unknown", described as "He reports arm soreness/soreness in arm".  Additional information: Consumer calling about the Pfizer COVID-19 vaccine who says he took it on March 3rd and has several questions about it. He says he was worried over something and may be paranoid but he didn't feel anything when he got the shot, which he was looking the other way because he was afraid of needles. He stated he did not feel anything when the needle went in and he was questioning whether he received the vaccine or not. He wants someone to tell him that he will be ok. He says he has soreness in his arm today so they did put the needle in, but he has no sickness they said he may feel in first two days, and now it is Friday he is wondering did they inject him and thinks he should have looked. He says he may be just stressed about it, he would like to know when they poked him with the needle and he is sore next day, is it because the needle was injected in his arm or because the medication is in there? Pfizer COVID-19 vaccine NDC/LOT/EXP: Unknown. Caller says he doesn't have his vaccine card, he remembers on the back it said second dose March 24th in three weeks. He says his other question was they had his last scheduled, how does this work, it doesn't show what time just the date of 24Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: she has sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 71 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 71 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "she had sore arm".  Additional information: Caller stated that the patient took her first dose of the Pfizer covid vaccine today, about 5 hours ago and had sore arm but no other symptoms. The patient also stated she had allergy shot due next week.  No follow-up attempts are possible. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Neck pain, Pain in extremity
Clinical narrative: pain in her upper back; pain under the neck; arm hurt and she could not move it; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 69 year-old female patient received bnt162b2 (BNT162B2), administration date 27Feb2021 09:00 (Batch/Lot number: unknown) at the age of 69 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BACK PAIN (non-serious) with onset 03Mar2021, outcome "unknown", described as "pain in her upper back"; NECK PAIN (non-serious) with onset 03Mar2021, outcome "unknown", described as "pain under the neck"; PAIN IN EXTREMITY (non-serious) with onset 27Feb2021, outcome "recovering", described as "arm hurt and she could not move it". Therapeutic measures were taken as a result of back pain, neck pain, pain in extremity.  Additional information: The patient asks if her symptoms may be related to the Pfizer-BioNTech COVID-19 vaccine or not. On Wednesday (03Mar2021) she noticed pain in her upper back, under the neck and she couldn't hold her head up. She took Aleve for the pain. It was described as pain similar to when the pillow was not well placed and after waking up the neck hurts. She wanted to know what should she do, can she get the next dose or not and asked what happens if she do not receive the second dose of the COVID-19 vaccine so she was referred to her Doctor for guidance related to the 2nd vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort
Clinical narrative: arm began to hurt; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LIMB DISCOMFORT (non-serious), outcome "recovered" (2021), described as "arm began to hurt". Therapeutic measures were taken as a result of limb discomfort.  Additional information included: she applied ice and arnica on the arm and pain went away.  No follow-up attempts are possible. No further information is expected.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia, Energy increased
Clinical narrative: slight metallic taste; energetic; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 32 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 10Feb2021 13:30 (Lot number: PAA156051) at the age of 32 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Some SVT in Heart" (unspecified if ongoing), notes: note : Some SVT in heart = supra ventricular tachycardia. There were no concomitant medications. The following information was reported: DYSGEUSIA (non-serious), outcome "unknown", described as "slight metallic taste"; ENERGY INCREASED (non-serious), outcome "unknown", described as "energetic".  Additional information: Following his first dose he only had light metallic taste, but then became energetic over the next two days, similar to that of a steroid shot. No other vaccine in four weeks and no other medications in two weeks. No covid prior vaccination and not tested covid post vaccination. No known allergies.  No follow-up attempts are possible. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Experienced sore arm and an itchy rash at the injection site one week after covid vaccine; Experienced sore arm and an itchy rash at the injection site one week after covid vaccine; an itchy rash at the injection site one week after covid vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 25Feb2021 14:00 (Lot number: EL3247) at the age of 50 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Raynauds Syndrome" (unspecified if ongoing). Concomitant medication(s) included: NIFEDIPINE; TYLENOL. The following information was reported: PAIN IN EXTREMITY (non-serious), VACCINATION SITE RASH (non-serious) all with onset 05Mar2021 07:00, outcome "not recovered" and all described as "Experienced sore arm and an itchy rash at the injection site one week after covid vaccine"; VACCINATION SITE PRURITUS (non-serious) with onset 05Mar2021, outcome "not recovered", described as "an itchy rash at the injection site one week after covid vaccine". Therapeutic measures were not taken as a result of pain in extremity, vaccination site rash, vaccination site pruritus.  Additional information: Patient was not administered any vaccine prior to covid vaccination. Patient had not underwent for covid test after vaccination. Patient was not reported any allergy.   No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Breast pain, Vaccination site pain
Clinical narrative: 12 hours after second vaccination I have persistent, sharp pain at the injection site and in the armpit and breast on the same side of my body as the arm that received the injection. It has perpetuate; Pain in the armpit; pain in the breast; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45 year-old male patient received bnt162b2 (BNT162B2), administration date 05Mar2021 11:15 (Batch/Lot number: unknown) at the age of 45 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: MULTI VITAMINS & MINERALS. Vaccination history included: Bnt162b2 (1st dose), for Covid-19 immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 05Mar2021 20:15, outcome "recovered" (2021), described as "12 hours after second vaccination I have persistent, sharp pain at the injection site and in the armpit and breast on the same side of my body as the arm that received the injection. It has perpetuate"; AXILLARY PAIN (non-serious) with onset 05Mar2021 20:15, outcome "recovered" (2021), described as "Pain in the armpit"; BREAST PAIN (non-serious) with onset 05Mar2021 20:15, outcome "recovered" (2021), described as "pain in the breast". Therapeutic measures were not taken as a result of vaccination site pain, axillary pain, breast pain.  Additional information: 12 hours after second vaccination patient had persistent, sharp pain at the injection site and in the armpit and breast on the same side of the body as the arm that received the injection. It perpetuated overnight at the same level of pain into the morning (at time of this report, still less than 24 hours since the patient received the vaccination). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. There were no known allergies. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: My husband described his left arm as being mildly sore after receiving his vaccination; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 48 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 04Mar2021 13:45 (Batch/Lot number: unknown) at the age of 48 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (unspecified if ongoing). Concomitant medication(s) included: FLUTICASONE. The following information was reported: MYALGIA (non-serious) with onset 05Mar2021, outcome "recovered", described as "My husband described his left arm as being mildly sore after receiving his vaccination". Therapeutic measures were not taken as a result of myalgia.  Additional information: Patient did not have other vaccine in four weeks. Patient did not received treatment for event. Patient did not covid prior vaccination and not teste post vaccination. Patient had no known allergies. My husband received his vaccination on Thursday, 04Mar not 03Mar. He mentioned to me that his arm was a bit sore on Friday evening 05Mar.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling abnormal, Feeling hot
Clinical narrative: At times feels tired, a few chills, and a little warm; At times feels tired, a few chills, and a little warm; At times feels tired, a few chills, and a little warm; felt bad; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56 year-old female patient received bnt162b2 (BNT162B2), administration date 24Feb2021 17:00 (Lot number: EN6202) at the age of 56 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Has narrow throat and nasal passages" (unspecified if ongoing); "Has narrow throat and nasal passages" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: FATIGUE (non-serious), CHILLS (non-serious), FEELING HOT (non-serious) all with onset 25Feb2021, outcome "not recovered" and all described as "At times feels tired, a few chills, and a little warm"; FEELING ABNORMAL (non-serious) with onset 2021, outcome "not recovered", described as "felt bad". Therapeutic measures were taken as a result of fatigue, chills, feeling hot, feeling abnormal.  Additional Information: The patient reported that she had narrow throat and nasal passages and it was hard for her to wear a mask. The patient was reported to be a front line worker. The patient did not take pills because of her narrow passages. She could take pills, but usually chops the pills up. The pills still felt like they were in her throat. The patient did not provide a specific product name when referring to this information. The patient did not take any medications, only reported to took vitamins every day. No further details were provided. The patient received vaccine on Wednesday last week (24Feb2021). The patient had been taking Ibuprofen when she felt bad. Took five ibuprofens (Lot: R85018, Exp.: Sep2022, Dose: 200mg blue mini gels; Only takes on mini gel at a time.) since last Wednesday. Took one dose of Kids Tylenol (Lot: SBM011, Exp.: Jan2022, Dose: Concentration is 160mg/5ml. She took 15ml and an hour and a half later still felt bad. She then took another 10ml. Only did this once). No investigational assessment was performed. It was reported that the patient had Pfizer COVID-19 shot last week. Feels ok, but "at times feels tired, a few chills, and a little warm". The patient wanted to know if this was normal. The patient stated this report was scaring her. The patient stated her symptoms were on the list, but it had been ongoing for more than five days (off and on). Wanted to make sure she was not feeling anything crazy. The patient wanted to know if she could take Ibuprofen or Tylenol. Stated she needed to know now what she could take. The patient was advised to follow up with her primary care physician.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Swollen lymph nodes; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-2021244007 (Pfizer).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LYMPHADENOPATHY (non-serious), outcome "unknown", described as "Swollen lymph nodes".  Additional Information: The patient was asking "if having swollen lymph nodes is part of the reaction to the vaccine". The patient declined to complete the report. No further clarification or details provided.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Nausea, Pain
Clinical narrative: I did have a 5 days of being very ill afterwards; Pain; Nausea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73 year-old female patient received bnt162b2 (BNT162B2), administration date 26Feb2021 (Batch/Lot number: unknown) at the age of 73 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing), notes: Verbatim: Hypertension. Concomitant medication(s) included: OLMESARTAN taken for hypertension; COREG taken for hypertension.  The following information was reported: ILLNESS (non-serious) with onset 27Feb2021, outcome "unknown", described as "I did have a 5 days of being very ill afterwards"; PAIN (non-serious) with onset 27Feb2021, outcome "unknown", described as "Pain"; NAUSEA (non-serious) with onset 27Feb2021, outcome "unknown", described as "Nausea". Therapeutic measures were taken as a result of pain, nausea.  Additional information: The reporter stated, she took something for pain and nausea. The patient had the Covid Vaccine (Pfizer Covid Vaccine) on February 26th and had 5 days of being very ill afterwards, it started the day after.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: Both my husband and I had a slight metallic taste after both shots; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 05Feb2021 13:00 (Lot number: EN 5318) at the age of 72 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "multiple allergies" (unspecified if ongoing). Concomitant medication(s) included: PROPRANOLOL; CRESTOR; VIT D. Vaccination history included: Bnt162b2 (product=COVID 19, brand=Pfizer, lot number=EL1283, administration time=10:30 AM, vaccine location=Right arm, dose number=1), administration date: 08Jan2021, when the patient was 72 years old, for COVID-19 immunisation, reaction(s): "metallic taste". The following information was reported: DYSGEUSIA (non-serious) with onset 05Feb2021 13:15, outcome "recovered" (2021), described as "Both my husband and I had a slight metallic taste after both shots". Therapeutic measures were not taken as a result of dysgeusia.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021251348 Same product and event, different patient
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: Both my husband and I had a slight metallic taste after both shots; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 05Feb2021 13:00 (Lot number: EN 5318) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose number=1, product=COVID 19, brand=Pfizer, lot number=EL1283, lot unknown=False, administration date=08Jan2021, administration time=10:30 AM, vaccine location=Right arm,), administration date: 08Jan2021, for Covid 19 Immunization. The following information was reported: DYSGEUSIA (non-serious) with onset 05Feb2021 13:15, outcome "recovered" (2021), described as "Both my husband and I had a slight metallic taste after both shots". Therapeutic measures were not taken as a result of dysgeusia.  Additional Information: Other vaccine in four weeks: No, Covid prior vaccination: No, Covid tested post vaccination: No  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021251310 Same product and event, different patient
Sex: M
Vaccine: COVID19
Symptoms: Somnolence
Clinical narrative: sleepy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as single dose for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SOMNOLENCE (non-serious), outcome "unknown", described as "sleepy".  Additional information: The reporter is the wife speaking about her husband. Caller reported that the reporter and her husband experienced sleepiness after the first dose Pfizer Covid shot. No further information provided by the caller.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Circumstance or information capable of leading to medication error, Malaise, Pain
Clinical narrative: This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) for a Pfizer sponsored program (159558). The reporter is the patient. A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (non-serious), outcome "unknown", described as "Caller is asking what she can do if she can't go to her 2nd dose schedule today"; MALAISE (non-serious), outcome "unknown", described as "not feeling very well"; PAIN (non-serious) with onset 01Mar2021, outcome "unknown", PAIN (non-serious), outcome "unknown" and all described as "she's feeling more achy than usual". Additional information: The caller's (name) return date for the 2nd dose is today, but she is not feeling very well. According to her, 3 days ago she's feeling more achy than usual. Caller is asking what she can do if she can't go to her 2nd dose schedule today. Medical Information: Were any unaddressed medical questions referred or forwarded to medical information: No. Is the reporter a healthcare professional (HCP): No? Occupation/Specialty: N/A. Is the reporter's contact information available to you or a sub-contracted party: Unknown? Is the reporter the prescribing HCP: Unknown; Name: Unknown; Address: Unknown; Occupation/Specialty: Unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Sensitivity to weather change
Clinical narrative: feeling under weather and would like to reschedule.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) for a PFIZER sponsored program.  A female patient received first dose of bnt162b2 (BNT162B2, Batch/Lot number: Unknown) as DOSE 1, SINGLE for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SENSITIVITY TO WEATHER CHANGE (non-serious), outcome "unknown", described as "feeling under weather and would like to reschedule."  Additional Information: No patient identifiers were provided but the reporter had first hand knowledge of the patient and was reporting on a specific patient, the reporter called for mother. The patient was supposed to have second dose of COVID-19 vaccine today. Today was 21 days. The patient was feeling under weather and would like to reschedule. Wondering if there was a grace period or leeway or how that worked.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: arm was barely sore; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) from medical information team. The reporter is the patient.  A 63-year-old male patient received first dose of bnt162b2 (BNT162B2, Batch/Lot number: Unknown) (age at the time of vaccination was 63-year-old) as DOSE 1, SINGLE for covid-19 immunization. Relevant medical history included: "knee pain" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "arm was barely sore"; HEADACHE (non-serious), outcome "unknown", described as "headache".  Additional Information: The patient got both of the PFIZER COVID-19 vaccine injections and the last one was on Monday. He had a history of knee pain for which he periodically got a steroid injection and he will eventually have surgery.He had a doctor appointment coming up and wonders if he can get the steroid injection in his knee. After his first PFIZER COVID-19 vaccine injection, his arm was barely sore and after the second one, his arm was sore for 24 hours and he got a little headache. In the past, he was on oral steroids and got the flu vaccine and he got sick as a dog.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: arm swelled up after the vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 52 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PERIPHERAL SWELLING (non-serious), outcome "unknown", described as "arm swelled up after the vaccine".  Additional Information: This consumer reported for his wife.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Bone pain, Illness
Clinical narrative: bones hurt; feels really sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 03Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Covid-19" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: BONE PAIN (non-serious) with onset Mar2021, outcome "unknown", described as "bones hurt"; ILLNESS (non-serious) with onset Mar2021, outcome "unknown", described as "feels really sick". Additional information: Caller reported having Covid before, said they had it was bad and felt really sick. Received dose yesterday, and says their bones hurt and feels really sick. Asked if needed second dose.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Asthenopia, Headache, Limb discomfort, Nausea, Pain in extremity
Clinical narrative: off and on light nausea; sore arm "a day, no big deal"; dull Headache; eyes get tired or fatigued; heavy at times; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (he experienced eye fatigue after 1st dose), for Covid-19 immunization, reaction(s): "eye fatigue"; Flu shot (flu shot usually makes me feel yucky for about a week), for feel yucky. The following information was reported: NAUSEA (non-serious), outcome "recovering", described as "off and on light nausea"; PAIN IN EXTREMITY (non-serious), outcome "recovering", described as "sore arm "a day, no big deal""; HEADACHE (non-serious), outcome "recovering", described as "dull Headache"; ASTHENOPIA (non-serious), outcome "recovering", described as "eyes get tired or fatigued"; LIMB DISCOMFORT (non-serious), outcome "recovering", described as "heavy at times".  Additional information: The patient at the age 68 (units unknown) reported. No PQC present in the case. The patient received both doses and 2nd dose was about 6 weeks ago.  The patient said did not any real intense side effects. All side effects haven nototally gone away, but Improving. But 6 weeks after dose- the patient was ready for it to be over . some days the patient had zero side effects, yesterday and the patient eyes still had the tired feeling. The patient said he read that some people have symptoms for a few days other months and had discussed this with doctors.  The patient said that  the "Infectious control doctor" said the symptoms could last for months.  The patient had reported post vaccination experience on the website.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Diarrhoea, Dizziness, Muscle spasms, Nausea
Clinical narrative: Dizzy; Nauseated; I was going to fall over every time I bent over to pick something, lost my balance and all day long I was like that; Have intense cramps; diarrhea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 65 year-old female patient received bnt162b2 (BNT162B2), administration date 27Feb2021 (Lot number: EN6202) at the age of 65 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Blood pressure high" (unspecified if ongoing), notes: Verbatim: High blood pressure; "High cholesterol" (unspecified if ongoing), notes: Verbatim: High cholesterol; "Osteopenia" (unspecified if ongoing), notes: Verbatim: Osteopenia. Concomitant medication(s) included: ATORVASTATIN taken for blood cholesterol increased; ALENDRONATE taken for osteopenia; METOPROLOL taken for hypertension. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "Dizzy"; NAUSEA (non-serious), outcome "unknown", described as "Nauseated"; BALANCE DISORDER (non-serious), outcome "unknown", described as "I was going to fall over every time I bent over to pick something, lost my balance and all day long I was like that"; MUSCLE SPASMS (non-serious), outcome "unknown", described as "Have intense cramps"; DIARRHOEA (non-serious), outcome "unknown", described as "diarrhea". Additional information: Patient stated "her doctor put her on a different medications (unspecified medications) and had been on it a month, so thought it was due to that medication because she thought the side effects of the Covid vaccine would came on her immediately like within 24 hours, so she didn't associated that with the Covid vaccine but she was now began to think that what it was because when she called her doctor anyway so she was reporting."  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Mammogram, Nervousness
Clinical narrative: bad headaches; Her whole body was jumping like she was getting shocked; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 66 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 11Feb2021 (Lot number: EN6200) at the age of 66 years as 1st dose, single for covid-19 immunisation. Relevant medical history included: "diagnosed allergies" (unspecified if ongoing); "compromised immune status" (unspecified if ongoing); "respiratory illness" (unspecified if ongoing); "genetic / chromosomal abnormalities" (unspecified if ongoing); "endocrine abnormalities" (unspecified if ongoing); "diabetes" (unspecified if ongoing); "obesity" (unspecified if ongoing); "illness" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE. The following information was reported: HEADACHE (non-serious) with onset Feb2021, outcome "recovered", described as "bad headaches"; NERVOUSNESS (non-serious) with onset Feb2021, outcome "recovered", described as "Her whole body was jumping like she was getting shocked". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: Did any AE(s) require a visit to: Emergency Room/ Physician Office.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Anaesthesia oral
Clinical narrative: This is a spontaneous report received from a non-contactable reporter(s) (consumer or other non-HCP) for a Pfizer sponsored program (159558). A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ANAESTHESIA ORAL (non-serious), outcome "unknown", described as "She stated her friend couldn't feel his tongue for 48 hours". Additional information: Caller spoke to corporate and was threatened with the security department. Pfizer does not care about her privacy or her wait time on calls. The Pfizer covid vaccine was an experiment and that many HCPs are not calling it a vaccine because it's not a vaccine. Covid has a 99% survival rate and its opened millions of people's eyes. We no longer have a government because it's controlled by pharma companies. She stated that back in the 40's pharmacy companies almost went bankrupt because of vaccines. She knows nurses who work in (State name) and that it was all a scare tactic. She stated that children are being forced with vaccines and that people are losing their jobs because they are not taking the vaccine. She stated her friend couldn't feel his tongue for 48 hours. She states that the virus mutates and lives in our DNA. She stated that the Pfizer vaccine was a cocktail and not a vaccine. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder
Clinical narrative: hard time sleeping after getting the first shot of the vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 14Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SLEEP DISORDER (non-serious) with onset 14Feb2021, outcome "unknown", described as "hard time sleeping after getting the first shot of the vaccine". No follow-up attempts are possible; information about lot/batch number cannot be obtained.  No follow-up attempts are needed; No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: This is a spontaneous report received from a contactable consumer or other non-HCP (patient), via a Pfizer sponsored program. A female patient received the 1st dose of BNT162B2 (Comirnaty, batch/lot# unknown), single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient experienced pain in extremity/pain in her hand, with outcome of recovered. Additional information: The patient woke up the next day and pain in her hand was gone. She was able to bend her fingers. It was unknown whether the reporter is a healthcare professional (HCP) and reporter the prescribing HCP or not. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: Tiredness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 04Mar2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: FATIGUE (non-serious) with onset Mar2021, outcome "unknown", described as "Tiredness".  Additional information: The patient wanted to know the side effect of tiredness and how long will it last? The patient had been feeling very tired and wanted to know how long he can go like this. Other Products, Patient History and Investigation Assessment were Not Provided.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: the arm soreness is normal and she felt that with the first dose; had a slight headache with first dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old female patient received bnt162b2 (BNT162B2), administration date 08Feb2021 16:20 (Lot number: EL9261) at the age of 57 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2021, outcome "unknown", described as "the arm soreness is normal and she felt that with the first dose"; HEADACHE (non-serious) with onset 2021, outcome "unknown", described as "had a slight headache with first dose". Therapeutic measures were not taken as a result of pain in extremity, headache.  Additional Information: The patient received the vaccine at care home for disabled. No investigation assessment was performed. It was reported that the patient knew "the arm soreness is normal and she felt that with the first dose". She had a slight headache with first dose. She did not take anything for it after the first dose and rode it out.  No follow-up attempts are possible. No further information is expected.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: My arm is sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 84 year-old female patient received bnt162b2 (BNT162B2), administration date 25Feb2021 (Batch/Lot number: unknown) at the age of 84 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "My arm is sore". Therapeutic measures were not taken as a result of pain in extremity.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: This is a spontaneous report received from contactable reporter(s) (Other HCP and consumer or other non-HCP). A female patient (unknown if pregnant) received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious) with onset 2021, outcome "recovered" (2021), described as "Patient reported in an informal setting that she got the vaccine a month ago and felt bad the next day". It was unknown if therapeutic measures were taken as a result of feeling abnormal. Response: I became aware of the adverse events on 04Mar2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Dizziness, Malaise
Clinical narrative: He is not hungry; just feeling unwell; Dizziness; Chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2), administration date 01Mar2021 (Lot number: EN6202) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: CHILLS (non-serious) with onset 03Mar2021, outcome "recovered" (04Mar2021), described as "Chills"; DECREASED APPETITE (non-serious) with onset 04Mar2021, outcome "unknown", described as "He is not hungry"; MALAISE (non-serious) with onset 04Mar2021, outcome "unknown", described as "just feeling unwell"; DIZZINESS (non-serious) with onset 04Mar2021, outcome "unknown", described as "Dizziness". Therapeutic measures were taken as a result of chills.  Additional information: The patient's wife was calling about her husband who took the Pfizer vaccine (Covid vaccine) on Monday (01Mar2021) and yesterday (03Mar2021) he had chills and he went to bed, all day. She gave him Tylenol, and well today (04Mar2021) he was still in bed but he does not have the chills, but he was not hungry, just feeling unwell and he has like dizziness today (04Mar2021), so she wanted to know is this normal or what she need to do.  No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Constipation, Feeling abnormal, Laboratory test
Clinical narrative: felt achy all over; chills; no energy; felt like in a "fog" for about 24 hours; constipation increase; This is a spontaneous report received from contactable reporter(s) (Other HCP) for a Pfizer sponsored program (060820).  A 62-years-old female patient received second dose of bnt162b2 (BNT162B2, Batch/Lot number: unknown) administration date 27Feb2021 (age at the time of vaccination was 62-years-old) as DOSE 2, SINGLE for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2, for COVID-19 immunisation. The following information was reported: PAIN (non-serious), outcome "recovering", described as "felt achy all over"; CHILLS (non-serious), outcome "recovering", described as "chills"; ASTHENIA (non-serious), outcome "recovering", described as "no energy"; FEELING ABNORMAL (non-serious), outcome "recovering", described as "felt like in a "fog" for about 24 hours"; CONSTIPATION (non-serious), outcome "recovering", described as "constipation increase". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: Patient reported labs stable, had Second COVID-19 vaccine on 27Feb2021 and felt achy all over, chills, no energy, felt like in a "fog" for about 24 hours and now some constipation increase. Feeling better this week. The patient was taking medication for 21 days on, 7 off.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: felt achy all over; chills; no energy; felt like in a "fog" for about 24 hours; constipation increase; This is a spontaneous report received from contactable reporter(s) (Other HCP) for a Pfizer sponsored program (060820).  A 62-years-old female patient received second dose of bnt162b2 (BNT162B2, Batch/Lot number: unknown) administration date 27Feb2021 (age at the time of vaccination was 62-years-old) as DOSE 2, SINGLE for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2, for COVID-19 immunisation. The following information was reported: PAIN (non-serious), outcome "recovering", described as "felt achy all over"; CHILLS (non-serious), outcome "recovering", described as "chills"; ASTHENIA (non-serious), outcome "recovering", described as "no energy"; FEELING ABNORMAL (non-serious), outcome "recovering", described as "felt like in a "fog" for about 24 hours"; CONSTIPATION (non-serious), outcome "recovering", described as "constipation increase". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: Patient reported labs stable, had Second COVID-19 vaccine on 27Feb2021 and felt achy all over, chills, no energy, felt like in a "fog" for about 24 hours and now some constipation increase. Feeling better this week. The patient was taking medication for 21 days on, 7 off.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Oropharyngeal pain, Pain
Clinical narrative: sore throat; mild body aches; headache; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 12Jan2021 (Lot number: EL3246) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: CELEBREX taken for antipyresis, start date: 12Jan2021 07:00. Vaccination history included: Bnt162b2 (Dose: 1), for Covid-19 immunisation. The following information was reported: OROPHARYNGEAL PAIN (non-serious) with onset 12Jan2021 21:00, outcome "recovered" (13Jan2021), described as "sore throat"; PAIN (non-serious) with onset 12Jan2021 21:00, outcome "recovered" (13Jan2021), described as "mild body aches"; HEADACHE (non-serious) with onset 12Jan2021, outcome "recovered" (13Jan2021), described as "headache". Therapeutic measures were not taken as a result of oropharyngeal pain, pain, headache.  Additional information: Vaccination Facility Type was hospital. Vaccine was not administered at military facility. Additional vaccine administered on same date of the Pfizer suspect was none. Family medical history relevant to AE was none. Prior to vaccine administration Celebrex 200 mg was used for antipyretic use (around the date of vaccination). The patient did not require to any visit to emergency room/physician office. There was a relationship possibility that the events were related to suspect product.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Injection site discomfort
Clinical narrative: mild discomfort at the injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40-year-old female patient received dose of bnt162b2 (BNT162B2, Batch/Lot number: unknown) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. Relevant medical history included: "Multiple sclerosis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: INJECTION SITE DISCOMFORT (non-serious), outcome "unknown", described as "mild discomfort at the injection site".  No follow-up attempts are possible. No further information is expected.